Cargando…

Network Modeling Identifies Patient-specific Pathways in Glioblastoma

Glioblastoma is the most aggressive type of malignant human brain tumor. Molecular profiling experiments have revealed that these tumors are extremely heterogeneous. This heterogeneity is one of the principal challenges for developing targeted therapies. We hypothesize that despite the diverse molec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuncbag, Nurcan, Milani, Pamela, Pokorny, Jenny L., Johnson, Hannah, Sio, Terence T., Dalin, Simona, Iyekegbe, Dennis O., White, Forest M., Sarkaria, Jann N., Fraenkel, Ernest
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926112/ https://www.ncbi.nlm.nih.gov/pubmed/27354287 http://dx.doi.org/10.1038/srep28668

Ejemplares similares

SteinerNet: a web server for integrating ‘omic’ data to discover hidden components of response pathways
por: Tuncbag, Nurcan, et al.
Publicado: (2012)

Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme
por: Tivnan, Amanda, et al.
Publicado: (2015)

Network-Based Interpretation of Diverse High-Throughput Datasets through the Omics Integrator Software Package
por: Tuncbag, Nurcan, et al.
Publicado: (2016)

TRANSLATIONAL RESEARCH-03 MULTIPLE MECHANISMS MODULATE TEMOZOLOMIDE RESISTANCE AND ARE POTENTIAL TARGETS FOR GLIOBLASTOMA THERAPY.
por: Kitange, Gaspar, et al.
Publicado: (2023)

Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements
por: Pirhaji, Leila, et al.
Publicado: (2017)

Brain Tumor Stem Cell Multipotency Correlates with Nanog Expression and Extent of Passaging in Human Glioblastoma Xenografts
por: Higgins, Dominique M., et al.
Publicado: (2013)

3D spatial organization and network-guided comparison of mutation profiles in Glioblastoma reveals similarities across patients
por: Dincer, Cansu, et al.
Publicado: (2019)

Quantitative Analysis of Signaling Networks across Differentially Embedded Tumors Highlights Interpatient Heterogeneity in Human Glioblastoma
por: Johnson, Hannah, et al.
Publicado: (2014)

Editorial: Targeted Therapies for Glioblastoma: A Critical Appraisal
por: Gupta, Shiv K., et al.
Publicado: (2019)

MARQUIS: A Multiplex Method for Absolute Quantification of Peptides and Post-Translational Modifications
por: Curran, Timothy G, et al.
Publicado: (2015)

Spectral flow cytometry identifies distinct nonneoplastic plasma extracellular vesicle phenotype in glioblastoma patients
por: Aibaidula, Abudumijiti (Zack), et al.
Publicado: (2023)

Perivascular Stromal Cells Instruct Glioblastoma Invasion, Proliferation, and Therapeutic Response within an Engineered Brain Perivascular Niche Model
por: Ngo, Mai T., et al.
Publicado: (2022)

Main Manuscript for Cell migration simulator-based biomarkers for glioblastoma
por: Hou, Jay, et al.
Publicado: (2023)

MDM2 Inhibition in the Treatment of Glioblastoma: From Concept to Clinical Investigation
por: Pellot Ortiz, Karolina I., et al.
Publicado: (2023)

Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells
por: Tivnan, Amanda, et al.
Publicado: (2017)

Pathway-based network modeling finds hidden genes in shRNA screen for regulators of acute lymphoblastic leukemia
por: Wilson, Jennifer L., et al.
Publicado: (2016)

Performance Assessment of the Network Reconstruction Approaches on Various Interactomes
por: Arici, M. Kaan, et al.
Publicado: (2021)

Functional stratification of cancer drugs through integrated network similarity
por: Unsal-Beyge, Seyma, et al.
Publicado: (2022)

Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy
por: Migliozzi, Simona, et al.
Publicado: (2023)

Quantifying Glioblastoma Drug Response Dynamics Incorporating Treatment Sensitivity and Blood Brain Barrier Penetrance From Experimental Data
por: Massey, Susan Christine, et al.
Publicado: (2020)

The novel BET inhibitor UM-002 reduces glioblastoma cell proliferation and invasion
por: Jermakowicz, Anna M., et al.
Publicado: (2021)

HotPoint: hot spot prediction server for protein interfaces
por: Tuncbag, Nurcan, et al.
Publicado: (2010)

Drug and disease signature integration identifies synergistic combinations in glioblastoma
por: Stathias, Vasileios, et al.
Publicado: (2018)

A Multi-Omics Interpretable Machine Learning Model Reveals Modes of Action of Small Molecules
por: Patel-Murray, Natasha L., et al.
Publicado: (2020)

Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma
por: Massey, Susan Christine, et al.
Publicado: (2020)

IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling
por: Oliva, Claudia R., et al.
Publicado: (2018)

LPA signaling is regulated through the primary cilium: a novel target in glioblastoma
por: Loskutov, Yuriy V., et al.
Publicado: (2018)

Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibition
por: Herrera-Perez, R. Marisol, et al.
Publicado: (2018)

HotSprint: database of computational hot spots in protein interfaces
por: Guney, Emre, et al.
Publicado: (2008)

PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity
por: Gupta, Shiv K., et al.
Publicado: (2019)

Crosstalk between microglia and patient-derived glioblastoma cells inhibit invasion in a three-dimensional gelatin hydrogel model
por: Chen, Jee-Wei Emily, et al.
Publicado: (2020)

Radiation Induced Metabolic Alterations Associate With Tumor Aggressiveness and Poor Outcome in Glioblastoma
por: Gupta, Kshama, et al.
Publicado: (2020)

BET bromodomain proteins are required for glioblastoma cell proliferation
por: Pastori, Chiara, et al.
Publicado: (2014)

SDPS-31 EXTRACELLULAR VESICLES AND THEIR CARGO AS A PHARMACODYNAMIC REPORTER IN GLIOBLASTOMA
por: DeLuca, Valerie, et al.
Publicado: (2023)

Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells
por: Harder, Bryan G., et al.
Publicado: (2019)

A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma
por: Lin, Wan-Hsin, et al.
Publicado: (2023)

Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
por: Randall, Elizabeth C., et al.
Publicado: (2018)

Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells
por: Narci, Kubra, et al.
Publicado: (2022)

Towards inferring time dimensionality in protein–protein interaction networks by integrating structures: the p53 example
por: Tuncbag, Nurcan, et al.
Publicado: (2009)

Pan-cancer clinical impact of latent drivers from double mutations
por: Yavuz, Bengi Ruken, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_og3jajl07ucfi1527ma455lfe1